Dr. Agarwals Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026

Ref: AHCL/2026-27/C049 October 23, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No C/1, G Block, Dalal Street, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai – 400 051 Scrip Code – 544350 Symbol : AGARWALEYE Dear Sir / Madam, Sub: Intimation of Board Meeting and Earnings / Analyst Conference Call Ref: Regulation 29 & 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to the captioned subject and reference, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, November 05, 2026, inter alia, to consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended September 30, 2026 (“Financial Results”). As intimated earlier, in terms of the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window shall remain closed until 48 hours after the announcement of the Financial Results. Further, the Company will host an Earnings / Analyst Conference on November 05, 2026, at 06:30 PM IST to discuss the Financial Results, and the dial-in details of which are enclosed herewith. This information is also made available on the website of the Company at: https://dragarwals.co.in/ We request you to kindly take the above on record. Thanking you, For Dr. Agarwal’s Health Care Limited Thanikainathan Arumugam Company Secretary and Compliance Officer Encl.: as above. Dr. Agarwal’s Health Care Limited Invite for Earnings/ Analyst Conference Call at 06:30 P.M. IST, November 05, 2026 Chennai, October 23, 2026: Dr. Agarwal’s Health Care Limited (BSE: 544350, NSE: AGARWALEYE) will host a conference call for the Investors and Analysts on Thursday, November 05, 2026, from 06:30 P.M. (IST) to 07:30 P.M. (IST) to discuss the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026. Dr. Agarwal’s Health Care Limited will be represented on the call by: Dr. Adil Agarwal – Whole-time Director and Chief Executive Officer Mr. Yashwanth Venkat – Chief Financial Officer Ms. Aashna Dharia – Head, Investor Relations Details of the conference call are as follows: Time: 06:30 P.M. IST (GMT +5.30) on Thursday, November 05, 2026 Dial-in Details: India: +91 22 6280 1308 / +91 22 7115 8161 International Toll Free Argentina 0080014243444 Japan 00531161110 Australia 0080014243444 Netherlands 08000229808 Belgium 0080014243444 Poland 008001124248 Canada 01180014243444 Singapore 8001012045 China 4008428405 South Korea 00180014243444 France 0800914745 Sweden 0080014243444 Germany 0080014243444 Thailand 00180014243444 Hong Kong 800964448 UK 08081011573 Italy 0080014243444 USA 18667462133 Express Join with Diamond Pass: https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=1070364&lin kSecurityString=96760fd28 You are requested to dial in 10 minutes ahead of the scheduled start time.